GZR-123

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameGZR-123
Drug Alias Nameneurotensin inhibitors (Russian Academy)neurotensin analogs (Russian Academy of Sciences)GZR-123
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors antagonistsNeurotensin receptors antagonists
TargetsDopamine receptorsNeurotensin receptors
Therapy Area/IndicationsPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRussian Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRussian Academy Of Medical Sciences
Active IndicationsN/A
Inactive IndicationsPsychotic Disorders

Other Information

ATC CodeN/A
Related LinksN/A